For the same 220-pound person, 22.5% means losing roughly 50 pounds, nearly 17 more pounds than semaglutide would produce on average
Research published in the journal Climacteric demonstrates that while weight gain itself cannot be attributed solely to menopause, the hormonal changes substantially alter where fat accumulates
Several personal and clinical factors may help determine the most appropriate time of day to administer retatrutide, should it become available to you through a clinical trial or, in future, via licensed prescription
Liraglutide (Saxenda) is also another GLP-1 receptor agonist that is FDA- approved for weight loss
Based on preclinical and early human data, activating all three pathways is thought to reduce appetite, improve insulin sensitivity, increase energy expenditure, and support fat breakdown effects that have shown substantial weight loss results in early-phase clinical trials, including a phase 2 study published in the New England Journal of Medicine (2023)
Obesity is reduces biologic efficacy, increases disease severity, and is independently associated with psoriatic arthritis risk